Table 1.
Study | Number of hips | Sensitivity | Specificity | PPV | NPV | Accuracy |
---|---|---|---|---|---|---|
Ali et al. [2] | 73 | 82% | 91% | 74% | 94% | 89% |
Barrack & Harris [5] | 260 | 50% | 88% | 6% | 99% | 87% |
Fehring & Cohen [13] | 166 | 50% | 88% | – | – | 87% |
Glithero et al. [20] | 54* | 89% | 97% | 94% | 95% | 94% |
Itasaka et al. [25] | 29 | 40% | 92% | 50% | 88% | 83% |
Johnson et al. [26] | 28* | 12% | 81% | 25% | 65% | 58% |
Kraemer et al. [28] | 45 | 57% | 97% | 89% | 83% | 84% |
Lachiewicz et al. [29] | 128 | 85% | 97% | – | – | 95% |
Levitsky et al. [30] | 72* | 67% | 96% | 75% | 94% | 91% |
Meermans & Haddad [36] | 120* | 83% | 100% | 100% | 35% | 84% |
Müller et al. [40] | 50 | 57% | 50% | 78% | 29% | 54% |
Panousis et al. [43] | 92* | 70% | 95% | 78% | 92% | 90% |
Somme et al. [47] | 109 | 83% | 100% | 100% | 86% | 92% |
Spangehl et al. [48] | 202 | 86% | 94% | 67% | 98% | – |
Steinbrink & Frommelt [49] | 2158 | 82% | 96% | 87% | 94% | 92% |
Teller et al. [50] | 166* | 28% | 99% | 83% | 90% | 90% |
Virolainen et al. [52] | 69* | 75% | 100% | – | – | – |
Williams et al. [53] | 273 | 80% | 94% | 81% | 93% | 90% |
* Total knee and hip arthroplasties; PPV = positive predictive value; NPV = negative predictive value.